Article in mSphere, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
4 authors.
Trevor Penix *Department of Host-Microbe Interactions, St Jude Children's Research Hospital, Memphis, Tennessee, USA.ORCID 0000-0003-0828-9323
Jenna Favazza *Department of Microbiology, Oregon State University, Corvallis, Oregon, USA.ORCID 0009-0007-0543-0965
Jason W Rosch *Department of Host-Microbe Interactions, St Jude Children's Research Hospital, Memphis, Tennessee, USA.ORCID 0000-0002-1798-1760
Hannah M Rowe *Department of Microbiology, Oregon State University, Corvallis, Oregon, USA.ORCID 0000-0002-2161-7996
Funding
Drug resistance enablers and their role in antibiotic treatment failureU19AI158076 · NIAID · BROAD INSTITUTE, INC. · PI VAN OPIJNEN, TIM · 2022 to 2025
$10.0M
Evolvable essentiality in the pan-genome of Streptococcus pneumoniae and its mechanistic and evolutionary consequencesR01AI171038 · NIAID · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI Jason W. Rosch, Federico Antonio Rosconi · 2022 to 2026
$3.0M
PspA binds necroptotic cells to cause disease and transmitR01AI156898 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI ORIHUELA, CARLOS J · 2020 to 2024
$2.0M
Consequences of Direct Viral-Bacterial InteractionsR56AI155614 · NIAID · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI ORTIZ-MARQUEZ, JUAN CESAR FEDERICO, ROSCH, JASON W. · 2021 to 2021
$531k
Characterization of TCS11 in Streptococcus pneumoniaeR21AI178084 · NIAID · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI MARGOLIS, ELISA B H, ROSCH, JASON W. · 2024 to 2025
$494k
Trivalent Live Attenuated Vaccines for Bacterial Acute Otitis MediaR21AI178085 · NIAID · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI ROSCH, JASON W. · 2024 to 2025
$494k
Medical Research Foundation of Oregon 2022 New InvestigatorNational Institute of Allergy and Infectious Diseases 1R21AI178085-01A1,1R21AI178084-01A, U19AI158076, 1R01AI155614, 1R01AI171038, R01AI156898NIAID NIH HHS R01 AI156898NIAID NIH HHS R01 AI171038NIAID NIH HHS R21 AI178084NIAID NIH HHS R21 AI178085NIAID NIH HHS R56 AI155614NIAID NIH HHS U19 AI158076
6 · The paper itself
Abstract
Synergy between influenza A virus (IAV) and
Indexed as
Influenza A virusLipopolysaccharidesStreptococcus pneumoniaeTeichoic AcidsVirus AttachmentCoinfectionHumansLipopolysaccharideslipoteichoic acidTeichoic Acidsinfluenzalipoteichoic acidStreptococcus pneumoniae
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Lipoteichoic acid mediates binding of · full record | OpenQuestion